Nureca Limited (NURECA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Nureca Limited stock ₹96.07, price ₹298, that is 67.8% below the price, quality 66 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Nureca Limited
NURECA · NSEFar too expensive (fair value 68% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹206.75 – ₹2,117 · fair‑value band ₹73.09 – ₹129.48 · the ₹298.25 price screens above the ₹96.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Every Wednesday you see whether Nureca is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Nureca Limited provides home healthcare and wellness products in India.
Show moreShow less
The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products.
It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, fitness trackers, and smart weighing scales.
In addition, the company provides orthopedic cushions, heating pads, and breast pumps. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites.
Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.
Stock analysis
Nureca Limited (NURECA) currently trades at ₹298.25, while our model-based Fair Value estimate is ₹96.07, 68% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹143.25 per share, and 0 of the 23 models we run sit above the ₹298.25 price.
Bear case: the Growth Earnings group reads lowest at ₹54.35, and 23 of the 23 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹73.09 (bear) to ₹129.48 (bull), the price of ₹298.25 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Nureca Limited reported revenue of ₹1.5B in FY2026 versus ₹2.6B in FY2022, a compound −12.9%/yr. Reported net income was ₹20.8M in FY2026, compounding −53.6%/yr from FY2022.
Key figures
Market cap ₹2.9B (≈ $31.2M) Micro · P/E ratio 63.7 · P/S ratio 1.74 · EPS (TTM) ₹4.72 · Net margin 2.7% · Return on equity 2.5% · Return on assets (EBIT) 2.1% (5-year average) · Operating margin 7.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (low confidence).
What moves the price
The share trades about 19% below its 52-week high and 44% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at −68%, NURECA screens richer than that median.
Fair Value models
All 23 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
NURECA screens overvalued: fair value 68% below the price. Compare with Abbott Laboratories, →
Compare Nureca Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stryker Corporation SYK | $309.64 | $340.60 | +10% | vs NURECA |
| Boston Scientific Corporation BSX | $44.34 | $48.77 | +10% | vs NURECA |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥179.40 | ¥197.34 | +10% | vs NURECA |
| DexCom, Inc DXCM | $83.33 | $91.66 | +10% | vs NURECA |
| STERIS plc STE | $264.32 | $281.90 | +7% | vs NURECA |
| GE HealthCare Technologies Inc GEHC | $83.02 | $69.92 | −16% | vs NURECA |
| Edwards Lifesciences Corporation EW | $107.15 | $81.94 | −24% | vs NURECA |
| Medtronic plc MDT | $102.86 | $74.90 | −27% | vs NURECA |
| Abbott Laboratories, ABT | $108.52 | $75.28 | −31% | vs NURECA |
| Koninklijke Philips N.V PHIA | €27.43 | €15.23 | −44% | vs NURECA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Nureca Limited (NURECA) overvalued or undervalued?
What is the fair value of NURECA?
What is the quality score of NURECA?
What is the price target for Nureca Limited (NURECA)?
What is the Nureca Limited stock forecast for 2026?
What is the revenue of Nureca Limited (NURECA)?
What growth is priced into Nureca Limited (NURECA)?
What discount rate (WACC) does the fair value of NURECA use?
What is a reverse DCF?
How much growth has Nureca Limited (NURECA) delivered so far?
How fast is the sector of Nureca Limited (NURECA) growing?
What is the free cash flow yield of Nureca Limited (NURECA)?
What is the intrinsic value of Nureca Limited (NURECA)?
Is Nureca Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of NURECA?
How much is Nureca Limited worth?
What do the bullish and bearish scenarios say about NURECA?
What is the P/E ratio of NURECA?
How solid is the balance sheet of Nureca Limited (NURECA)?
How far is NURECA from its 52-week high?
Which stocks are comparable to Nureca Limited?
Is Nureca Limited stock attractive at the current price?
How is the fair value of NURECA calculated?
Is it still worth investing in stocks now?
What is the share price of Nureca Limited (NURECA)?
What should I pay attention to with Nureca Limited right now?
Key figures of Nureca Limited
How large is the market capitalisation of Nureca Limited (NURECA)?
What is the P/S ratio of Nureca Limited (NURECA)?
What are the earnings per share of Nureca Limited (NURECA)?
What is the net margin of Nureca Limited (NURECA)?
What is the return on equity of Nureca Limited (NURECA)?
What is the EBIT return on assets of Nureca Limited (NURECA)?
What is the operating margin of Nureca Limited (NURECA)?
How fast is revenue growing at Nureca Limited (NURECA)?
How fast are earnings growing at Nureca Limited (NURECA)?
How much net cash does Nureca Limited (NURECA) hold?
Watch Nureca Limited in the live analysis
One click puts Nureca Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.